NWBO vs. DNA
Compare and contrast key facts about Northwest Biotherapeutics, Inc. (NWBO) and Ginkgo Bioworks Holdings, Inc. (DNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NWBO or DNA.
Key characteristics
| NWBO | DNA | |
|---|---|---|
| YTD Return | -64.29% | -88.71% |
| 1Y Return | -68.35% | -88.37% |
| 3Y Return (Ann) | -40.03% | -76.27% |
| Sharpe Ratio | -1.10 | -0.88 |
| Sortino Ratio | -2.43 | -2.11 |
| Omega Ratio | 0.75 | 0.78 |
| Calmar Ratio | -0.70 | -0.88 |
| Martin Ratio | -1.44 | -1.42 |
| Ulcer Index | 48.22% | 61.56% |
| Daily Std Dev | 63.01% | 100.05% |
| Max Drawdown | -99.99% | -99.10% |
| Current Drawdown | -99.98% | -98.72% |
Fundamentals
| NWBO | DNA | |
|---|---|---|
| Market Cap | $312.06M | $430.71M |
| EPS | -$0.07 | -$18.00 |
| Total Revenue (TTM) | $1.24M | $128.91M |
Correlation
The correlation between NWBO and DNA is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NWBO vs. DNA - Performance Comparison
In the year-to-date period, NWBO achieves a -64.29% return, which is significantly higher than DNA's -88.71% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NWBO vs. DNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Northwest Biotherapeutics, Inc. (NWBO) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NWBO vs. DNA - Dividend Comparison
Neither NWBO nor DNA has paid dividends to shareholders.
Drawdowns
NWBO vs. DNA - Drawdown Comparison
The maximum NWBO drawdown since its inception was -99.99%, roughly equal to the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for NWBO and DNA. For additional features, visit the drawdowns tool.
Volatility
NWBO vs. DNA - Volatility Comparison
The current volatility for Northwest Biotherapeutics, Inc. (NWBO) is 12.54%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 22.61%. This indicates that NWBO experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NWBO vs. DNA - Financials Comparison
This section allows you to compare key financial metrics between Northwest Biotherapeutics, Inc. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities